Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-145"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"sk"^^xsd:language2
lpv:document identification number	"en.20100922.20.3-145"2
lpv:hasSubsequent	lp_eu:2010-09-22-Speech-3-1462
lpv:speaker	lp:Anna Záborská2
lpv:spokenAs	substitute; ENVI (2009-07-16--2012-01-18)3 member; Delegation for relations with Canada (2009-09-16--2014-06-30)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 member; FEMM (2009-07-16--2012-01-18)3 member; DEVE (2009-07-16--2012-01-18)3 member_of_the_bureau; EPP (2009-09-16--2014-06-30)3 unknown; Kresťanskodemokratické hnutie (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the Pan-African Parliament (2009-09-16--2014-06-30)3
lpv:translated text	"I would like to congratulate the rapporteur on the text she has drafted as an amendment to the two directives on pharmacovigilance. It is important to make full use of what these amendments offer us. We will only counter the fears of some Member States concerning the workability of the system if the reporting of adverse effects is coordinated. The time lost in sharing information between Member States must be minimal. One more comment: statistics show that diseases are more frequent among older and elderly people. These are people who quite naturally suffer from failing eyesight. It will be pointless for accompanying leaflets to contain comprehensive information, including often unnecessary information, if patients cannot read it even with their normal glasses, as the print is also tiny."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph